WBRZ: Louisiana native working in fight against coronavirus as antibody manufacturer
ImmunoReagents and Vice President & CSO Dr. Tee Bordelon have been recognized in an article from WBRZ Louisiana for their efforts in aiding with Coronavirus research.
May 13, 2020 — "A simple blood test can determine if you've been exposed to the coronavirus and if you've developed antibodies. Tee Bordelon, a Broadmoor High School and LSU graduate, is now the Vice President and Chief Scientific Officer at ImmunoReagents, Inc in Raleigh, NC. Bordelon and his team have been working over the last two months to supply diagnostic companies throughout the country on critical antibodies needed and being used in the fight against COVID-19. Read More
ImmunoReagents Hires Quality Assurance Manager for ISO Certification
Exporter of Exceptional Immunoassay Reagents is Pursuing ISO13485 Certification
February 14, 2019 — Read More
ImmunoReagents CEO Dr. Ann Black Receives Governor's Export Award in Raleigh, NC
On January 14, 2019 ImmunoReagents was recognized for excellence in exporting.
January 23, 2019 — Read More
ImmunoReagents and Dianova GmbH Announce Corporate Alliance
ImmunoReagents and Dianova GmbH Announce Corporate Alliance
July 20, 2018 — ImmunoReagents and Dianova GmbH Announce Corporate Alliance Read More
ImmunoReagents and BIOCARE MEDICAL Announce Corporate Alliance
ImmunoReagents and BIOCARE MEDICAL Announce Corporate Alliance
June 08, 2018 — ImmunoReagents and BIOCARE MEDICAL Announce Corporate Alliance Read More
Bioprocess International White Paper
The Forgotten Immunoglobulin LigaTrap™ Technologies and Advancements in IgM Purification
September 07, 2017 — It's been over 30 years since the identification and commercialization of protein A. Since its inception protein A has served as the pinnacle purification platform for the immunoglobulin G (IgG) subclass of antibodies, both monoclonal and polyclonal forms. The introduction of protein A paved the way for researchers and large pharmaceutical manufacturers to develop and commercialize IgG-based therapeutics at both small and large scales, provided by its relative ease of use and well-characterized chromatographic attributes. Unfortunately, the gold standad affinity ligand, protein A, does not bind to all immunoglobulin subclasses, including immunoglobulin M (IgM0, thereby forcing those working with IgM to find alternative purification strategies and leaving IgM to hitchhike on that "yellow brick road" that protein A offers so readily for IgG. Read More
ImmunoReagents and BIOZOL Announce Corporate Alliance
August 18, 2017 — ImmunoReagents and BIOZOL Announce Corporate Alliance Read More
ImmunoReagents 2017-2018 EU Certification NC-TEC-0004
May 31, 2017 — ImmunoReagents has been recertified by the USDA to export goat, rabbit, bovine, sheep, llama, porcine, chicken, turkey, mouse, rat, and guinea pic blood products for compliance with Regulation (EC) 142/2011. ImmunoReagents was approved by APHIS. Read More
ImmunoReagents, Inc. Releases LigaTrap™ IgM Purification Resin and Kit
March 31, 2017 RALEIGH, NC, USA –ImmunoReagents, Inc. is excited to add Human IgM Purification Resin and Kits to its portfolio of LigaTrap™ purification products.
Read MoreImmunoReagents Re-approved by USDA/APHIS
July 06, 2015 — ImmunoReagents has gained certification by the USDA to export goat, rabbit, bovine, sheep, llama, porcine, chicken, turkey, mouse, rat, and guinea pic blood products for compliance with Regulation (EC) 142/2011. ImmunoReagents was approved by APHIS. Read More
ImmunoReagents Wins 2015 President’s “E” Award
Honored for outstanding export success
May 20, 2015 — RALEIGH, NC, USA – May 19, 2015 – U.S. Secretary of Commerce Penny Pritzker has presented ImmunoReagents with the President’s “E” Award for Exports at a ceremony in Washington, DC. The President’s “E” Award is the highest recognition any U.S. entity can receive for making a significant contribution to the expansion of U.S. exports. Dr. Ann Black, President and CEO of ImmunoReagents, accepted the award at The U.S. Department of Commerce. Read More
ImmunoReagents and Shenandoah Biotechnology Announce Corporate Alliance and New Product Launch
April 30, 2015 — RALEIGH, NC, USA – April 28, 2015 – Leading Life Science Reagent Manufacturer ImmunoReagents joins forces with Shenandoah Biotechnology, the industry’s leading manufacturing of recombinant proteins. “New proteins are being identified every day by research labs around the world. To determine the significance of these proteins, the researchers need the proper tools,” said Dr. Ann Black. “That is why our relationship with Shenandoah Biotechnology is so important. We are now able to provide precise antibody tools needed to support ongoing, cutting edge research. Working with Shenandoah Biotech, ImmunoReagents will continue to expand our line of primary research antibodies for use in a variety of Immunoassay formats.” Pamela De Lacy at Shenandoah talks about the partnership, "Shenandoah is discontinuing our antibody line of products because we want to be able to solely focus on what we excel at--world class recombinant proteins. By transferring our antibody product line to ImmunoReagents Inc, we can focus exclusively on bringing new high quality recombinant proteins to the research market while expanding ImmunoReagents offerings of high quality antibodies. Working together to expand a complete line of antigens, antibodies and ELISA kits in future collaborative projects, the partnership will benefit our customers by providing all of the tools a scientist needs to paint a complete scientific picture." About ImmunoReagents, Inc. ImmunoReagents, Inc. is a leading global manufacturer of quality antibodies and reagents used in pharmaceutical research, life science research and in vitro diagnostics. Product offerings include a wide range of immunochemistry reagents such as purified immunoglobulins, primary antibodies, and secondary antibodies covering a broad spectrum of immunoglobulins from various species. ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The company is located in Raleigh, North Carolina. For more information, please see www.immunoreagents.com About Shenandoah Inc. Shenandoah specializes in the manufacturing of recombinant proteins from E.coli. Our catalog of products is focused on proteins used as cytokines, chemokines and growth factors used in a wide variety of research applications and cell culture systems. We are dedicated to providing cytokines for all areas of research including cancer, stem cell biology, immunology, developmental biology and many others. In addition to our catalog, we provide custom services that include inclusion body protein folding and purification, custom protein expression, and bulk (milligrams to grams) protein production. Shenandoah is proud to be a small American business that aims to put scientists first. We like to think of ourselves as 'Your Mom and Pop Protein Shop' and feel that our customer service and personal attention reflect that sentiment. For more information, please see www.shenandoah-bt.com Read More
Ice Bucket Challenge Complete!
September 04, 2014 — Dr. Ann Black has completed the ice bucket challenge! Watch the video to see who she nominates next, and of course to see her get soaked! Read More
Ice Bucket Challenge!
September 04, 2014 — Dr. Ann Black, President of ImmunoReagents Inc, has been officially nominated to take the Ice Bucket Challenge by John Loyack, Director of International Trade with the NC Department of Commerce! She will be taking the challenge later this evening, so be sure to come back and check out the video! Read More
ImmunoReagents, Inc. Holds Ribbon Cutting Ceremony
RALEIGH, NC—ImmunoReagents, Inc. recently held a ribbon cutting ceremony at their new production facility at 6003 Chapel Hill Road in Raleigh, NC.
May 15, 2014 — Read More
ImmunoReagents Relocation For February 2014
January 08, 2014 — Dear Clients, Read More
ImmunoReagents and ImmunO4 Announce Strategic Business Alliance and Corporate Partnership
July 26, 2013 — ImmunoReagents and ImmunO4 Announce Strategic Business Alliance and Corporate Partnership Read More
ImmunoReagents Wins 2013 North Carolina Exporter of the Year
June 24, 2013 — By Virginia Bridges — [email protected] Read More
ImmunoReagents Nominated as "Exporter of the Year" by WBC of North Carolina
February 13, 2013 — ImmunoReagents was nominated as "Exporter of the Year" by the WBC of North Carolina. Read More
ImmunoReagents Enters Distributorship Agreement with Abyntek Biopharma; Key Spanish Supplier of Antibodies
February 07, 2013 — (Raleigh, NC) -- ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced Abyntek Biopharma as its new distributor in Spain. Read More
